Macquarie Group Ltd. purchased a new position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 7,791 shares of the company’s stock, valued at approximately $289,000.
A number of other hedge funds have also made changes to their positions in PAHC. Janus Henderson Group PLC acquired a new position in Phibro Animal Health during the 2nd quarter worth $6,353,000. AJO LP acquired a new stake in shares of Phibro Animal Health in the second quarter valued at $5,815,000. FMR LLC lifted its holdings in shares of Phibro Animal Health by 31.9% in the second quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after buying an additional 141,274 shares during the period. Ameriprise Financial Inc. lifted its holdings in shares of Phibro Animal Health by 50.6% in the second quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock valued at $12,599,000 after buying an additional 114,230 shares during the period. Finally, Mckinley Capital Management LLC Delaware acquired a new stake in shares of Phibro Animal Health in the second quarter valued at $4,116,000. Institutional investors own 48.42% of the company’s stock.
Several analysts have recently weighed in on the company. Piper Jaffray Companies set a $41.00 price objective on Phibro Animal Health and gave the company a “buy” rating in a report on Friday, October 6th. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. BidaskClub lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Credit Suisse Group upped their price objective on Phibro Animal Health from $36.00 to $37.00 and gave the company an “outperform” rating in a report on Thursday, August 31st. Finally, ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $38.25.
Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.01. The business had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The company’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 earnings per share. analysts forecast that Phibro Animal Health Corp will post 1.57 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 23.53%.
Phibro Animal Health Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.